Risk Factors for Mortality Among Patients on Hemodialysis in India: A Case-Control Study

Pub Date : 2024-08-08 DOI:10.25259/ijn_563_23
Suresh Sankarasubbaiyan, Carol A. Pollock, Urmila Anandh, Savitha Kasiviswanathan, Kamal D. Shah
{"title":"Risk Factors for Mortality Among Patients on Hemodialysis in India: A Case-Control Study","authors":"Suresh Sankarasubbaiyan, Carol A. Pollock, Urmila Anandh, Savitha Kasiviswanathan, Kamal D. Shah","doi":"10.25259/ijn_563_23","DOIUrl":null,"url":null,"abstract":"\n\nMortality in hemodialysis (HD) exceeds that of many solid organ cancers, despite advancements in care. This study was conducted to understand mortality in a large dialysis network of Indian HD patients and attempt to elucidate risk factors for mortality.\n\n\n\nWe performed a case-control study of deaths among patients undergoing HD across 203 centers in India from January 1 to March 31, 2021 with an age-matched control of survivors. We reviewed demographic, dialysis, clinical, and socioeconomic factors.\n\n\n\nOut of 17,659 patients on dialysis, 554 cases (non-survivors) and 623 age-matched controls (survivors) patients were followed up. The mean age was 54.9 ± 13.8 years, 70.5% (391) of them were males. Gender, BMI, dialysis frequency, HD vintage time, history of diabetes, and heart failure were similar between non-survivors and survivors. Lower education level, payment under public insurance, dialysis facility under a public-private partnership, vascular access via catheter, hemoglobin <8 g/dL levels, serum albumin <3.5 g/dL were significantly higher, hospitalizations in 3 months prior to death were more frequent among non-survivors.\n\n\n\nFactors including Hb <8 g/dL, temporary catheter, serum albumin less <3.5 g/dL, lower educational status, and dialysis under public insurance are associated with poorer survival in our population. Our findings have implications for designing interventions needed to improve outcomes for evolving policy and public-payer systems.\n","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ijn_563_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Mortality in hemodialysis (HD) exceeds that of many solid organ cancers, despite advancements in care. This study was conducted to understand mortality in a large dialysis network of Indian HD patients and attempt to elucidate risk factors for mortality. We performed a case-control study of deaths among patients undergoing HD across 203 centers in India from January 1 to March 31, 2021 with an age-matched control of survivors. We reviewed demographic, dialysis, clinical, and socioeconomic factors. Out of 17,659 patients on dialysis, 554 cases (non-survivors) and 623 age-matched controls (survivors) patients were followed up. The mean age was 54.9 ± 13.8 years, 70.5% (391) of them were males. Gender, BMI, dialysis frequency, HD vintage time, history of diabetes, and heart failure were similar between non-survivors and survivors. Lower education level, payment under public insurance, dialysis facility under a public-private partnership, vascular access via catheter, hemoglobin <8 g/dL levels, serum albumin <3.5 g/dL were significantly higher, hospitalizations in 3 months prior to death were more frequent among non-survivors. Factors including Hb <8 g/dL, temporary catheter, serum albumin less <3.5 g/dL, lower educational status, and dialysis under public insurance are associated with poorer survival in our population. Our findings have implications for designing interventions needed to improve outcomes for evolving policy and public-payer systems.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
印度血液透析患者死亡的风险因素:病例对照研究
尽管医疗技术不断进步,但血液透析(HD)的死亡率超过了许多实体器官癌症。我们对 2021 年 1 月 1 日至 3 月 31 日期间印度 203 个中心接受血液透析的患者死亡情况进行了病例对照研究,并对幸存者进行了年龄匹配对照。在 17659 名透析患者中,我们对 554 名病例(非幸存者)和 623 名年龄匹配的对照组(幸存者)患者进行了随访。平均年龄为 54.9 ± 13.8 岁,其中 70.5% (391 人)为男性。非幸存者和幸存者的性别、体重指数、透析频率、血液透析时间、糖尿病史和心力衰竭情况相似。教育程度较低、公共保险支付、公私合作透析机构、通过导管接入血管、血红蛋白水平<8 g/dL、血清白蛋白<3.5 g/dL等因素在非存活者中明显较高,非存活者在死亡前3个月内住院的频率较高。我们的研究结果对设计干预措施具有重要意义,这些干预措施可改善不断变化的政策和公共付费系统的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1